Please ensure Javascript is enabled for purposes of website accessibility

health care stocks

Aktis Oncology secures Lilly as anchor investor for upsized US IPO
Jan 7, 2026

Aktis Oncology secures Lilly as anchor investor for upsized US IPO

Jan 7 (Reuters) – Cancer drug developer Aktis Oncology said on Wednesday it was targeting a valuation of up to $945.4 million in its upsized initial public offering, signaling strong investor demand for 2026’s first U.S. listing. The Boston, Massachusetts-based company has also drawn in Eli Lilly to anchor the IPO, with the pharma giant […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.